The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site.

All material subject to strictly enforced copyright laws. © 2020 Euromoney, a part of the Euromoney Institutional Investor PLC.
Opinion

Sugita’s sickness

       
Katsuyuki Sugita

In early May, Katsuyuki Sugita, president of Dai-Ichi Kangyo Bank (DKB) and co-CEO of the newly created Mizuho Bank, returned to duty from sick leave. He made all the right noises to staff that he was fighting fit - "full of power and energy" - and ready to play a full part in the next stage of the merger of DKB, Fuji Bank and Industrial Bank of Japan (IBJ).


But insiders fear that Sugita's sickness will make the infighting for top jobs in Mizuho the more intense. A suspicious Mizuho spokesman asks how Euromoney has heard of Sugita's illness, before describing it as cystic duct narrowing. Rumours persist of an even more serious condition.


Until now, it was widely assumed that Sugita would become the head of the Mizuho holding company, leaving the president of IBJ, Masao Nishimura, to head the corporate bank and Yoshiro Yamamoto, president of Fuji Bank, to take charge of the commercial bank - a neat division of the spoils.



Take out a complimentary trial

Take out a 7 day trial to gain unlimited access to Euromoney.com and Asiamoney.com analysis and receive expertly-curated updates direct to your inbox.

 

Already a user?

Login now

 

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree